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Background
Abnormal gastrointestinal permeability (GIP) has been
implicated in immunologic disease, including Crohn’s dis-
ease and celiac disease, but also including non-intestinal
diseases such as diabetes and multiple sclerosis. Abnormal
GIP may lead to entry of allergens from the gut into the
systemic circulation and may prime the immune system,
inciting inflammation outside the gut.
Hypothesis
Adult asthmatics demonstrate abnormal small bowel GIP.
Methods
GIP in ten patients followed in a regional referral centre
in Northern Alberta was assessed. Patients were classi-
fied as allergic versus non-allergic on the basis of skin
allergen testing. GIP was evaluated using an assay with
established normal range values. Patients ingested a
solution containing sucrose, mannitol and lactulose and
urine was collected and assayed using high-performance
liquid chromatography. Retrospectively, patient records
were reviewed, and in addition to demographics, airway
physiology, atopy, and sputum cell counts (SCCs) were
captured.
Results
5 of 10 patients had increased GIP (Figure 1). Patients
with abnormal GIP were not more likely to have evidence
of active airway inflammation as assessed by SCC. There
was no association between atopy and abnormal GIP.
Discussion
This study demonstrates an increase in GIP in the MALT-
rich small intestine of asthmatic patients, illustrating an
association between abnormal GIP and current asthma.
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Figure 1 GIP is increased in patients with asthma. Panel A
represents the lactulose to mannitol ratio (Lac/Man) among the
study cohort, measured by HPLC. Panel B represents the absorbed
sucrose levels among the same patients. Each data point represents
an individual patient. Circled data points indicate the patient had an
abnormal sputum analysis (solid circles, eosinophilia; dashed circles,
neutrophilia). In both panels, the dashed X-axis has been set at the
value corresponding to the established upper limit of normal in
healthy control patients.
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inflammation. Abnormal GIP may be an important deter-
minant of allergenic entry into the systemic circulation,
and the absence of a correlation between active airway
inflammation and increased GIP suggests a primary defect
in the immunologic barrier.
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